Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatment for patients.

However, in some people, the response causes excess production of fibrinogen (a protein that helps with blood clotting) and collagen (a protein that supports the skin). When this occurs ...